LUU BRENDAN (Sr. VP, Business Dev.) sold 3.5% of their position (1.39K shares) of ENANTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $19.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2025ACC: 0002064832-25-000063
Officer· Sr. VP, Business Dev.
Since Jan 2021
-1.39K
Net shares
Net seller
$19.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.39K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.39K
Price / share
$14.23
Trade value
$19.84K
% of position
3.5%
12/5/2025
39.72K→38.33K
Total
Net shares
−1.39K
Net value
-$19.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | S · Sale | −1.39K | $14.23 | $19.84K | 3.5% | 39.72K | 38.33K |
| Total | −1.39K | -$19.84K | ||||||
Derivative Transactions0
No derivative transactions reported